about
Autolysosomal β-catenin degradation regulates Wnt-autophagy-p62 crosstalkHypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumorsFrequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.Genome-wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastomaA novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathwayEpigenetic gene deregulation in cancer.The parathyroid hormone-responsive B1 gene is interrupted by a t(1;7)(q42;p15) breakpoint associated with Wilms' tumour.Wilms' tumor: a paradigm for the new genetics.A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis.Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter.LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma.The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosisProtein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells.Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma.Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A.Characterization of 17.94, a novel anaplastic Wilms' tumor cell line.Identification of novel Wilms' tumor suppressor gene target genes implicated in kidney development.Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways.The retinoblastoma protein interacts with Bag-1 in human colonic adenoma and carcinoma derived cell lines.Cloning and sequencing of the cDNA encoding a mouse tissue inhibitor of metalloproteinase-2.Wnt Signalling Drives Context-Dependent Differentiation or Proliferation in Neuroblastoma.Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axisFrequency and Timing of Loss of Imprinting at 11p13 and 11p15 in Wilms' Tumor DevelopmentWnt signalling drives context-dependent differentiation or proliferation in neuroblastomaInduction of apoptosis by the 16-kDa amino-terminal fragment of the insulin-like growth factor binding protein 3 in human colonic carcinoma cellsThe molecular biology of Wilms' tumourTransactivation of the WT1 antisense promoter is unique to the WT1[+/−] isoformAutoregulation of the human WT1 gene promoterWnt Signaling Is a Major Determinant of Neuroblastoma Cell LineagesThe molecular biology of Wilms tumourA Wnt-BMP4 Signaling Axis Induces MSX and NOTCH Proteins and Promotes Growth Suppression and Differentiation in NeuroblastomaEpigenetic deregulation of GATA3 in neuroblastoma is associated with increased GATA3 protein expression and with poor outcomesPRMT1 promotes neuroblastoma cell survival through ATF5
P50
Q24294545-3D05145B-2D09-4609-9A94-F104E5AB2E00Q24678285-9A2880A3-77A4-4F4B-9E2D-85596A3D00C6Q30945124-15C5E763-1BB6-4CFA-85C7-FDB8BC68E34AQ33578303-669B0C20-4CD8-4287-996B-0CCBA5732682Q33825059-35FB7E82-BE8B-4EDC-9DCD-DD1A8400C916Q34097482-FDAD5B93-0A35-460C-9A16-C3FA67F0D1F0Q34181512-2DAFBD05-AE14-4E38-8DD6-349EE2747ACBQ34591857-C7E54BFB-99C4-45D2-B132-4AF4E7280648Q34599448-D9116978-EC54-475A-851A-0A2168FFEA93Q35509305-5E577CB5-7FF6-4E58-9FE2-4541B588B715Q38261762-AE82FA4C-B5F9-4ACC-A2DA-42AD97B372D0Q38700629-80D7FCE8-02C2-4189-8166-FC7046BFC424Q38932230-2D612C2F-1E29-4EE9-93CD-020611389B5AQ39236500-E8CF238F-D981-478D-BA48-57D9E0EC83AEQ39264413-A7093EE7-ED6D-491F-AF79-B2F2B60DC925Q39322422-18197126-1B7E-4E20-AAFB-1005F9A3BBD4Q40146414-246BA028-4D75-4DCA-B654-12FF7EEACD8DQ40492521-B1CBBC2B-1302-44B5-8086-1CB20389C505Q44503115-12716228-EFD9-4700-AAB8-495DF6DA1BDAQ48172900-F322DC46-53B4-4D5D-A8EE-FD147981CEDFQ52673795-38B9FD24-96D7-42B3-A4A5-A2F1F19A2743Q52957891-0188236F-5DFD-4642-B231-BA9C698E3B2CQ57247080-2C7FFA59-147D-420E-8287-130AFD8C1268Q57727362-4A771824-7D1B-4DB4-9546-A25FB1C69428Q63364737-68DB318D-BC13-4288-B2F1-CA05F37531B7Q63722710-82736AAA-3547-4CB8-988E-0BB38FF3F78CQ63722719-BFC46CCA-4B9A-4624-96E3-EAA169F9E8FAQ63722725-2BFA1540-10CA-43AA-B269-B9BA78FFFD9CQ63722729-17E59270-C66F-41DA-A641-FA21A30F2D6AQ64108352-71FD59AD-90E0-4D26-8868-AE73B6E9279AQ76384884-D27473C6-7B7D-41C1-A4AC-AB25146F8B2DQ90632923-31548C31-5C14-4B70-85FA-1169D9070EF6Q91933513-0C56E339-B5D2-43F3-802B-EDB42ADD2142Q94948335-98E36CC1-C976-4537-9E7A-5F1427100712
P50
description
researcher
@en
հետազոտող
@hy
name
Karim Malik
@ast
Karim Malik
@en
Karim Malik
@es
Karim Malik
@nl
type
label
Karim Malik
@ast
Karim Malik
@en
Karim Malik
@es
Karim Malik
@nl
prefLabel
Karim Malik
@ast
Karim Malik
@en
Karim Malik
@es
Karim Malik
@nl
P106
P21
P31
P496
0000-0002-8965-200X